BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12084460)

  • 1. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA.
    Chu J; Dolnick BJ
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):183-93. PubMed ID: 12084460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel function for the rTS gene.
    Dolnick BJ; Angelino NJ; Dolnick R; Sufrin JR
    Cancer Biol Ther; 2003; 2(4):364-9. PubMed ID: 14508106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
    DeMoor JM; Vincent MD; Collins OM; Koropatnick J
    Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA.
    Lin X; Parsels LA; Voeller DM; Allegra CJ; Maley GF; Maley F; Chu E
    Nucleic Acids Res; 2000 Mar; 28(6):1381-9. PubMed ID: 10684933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternate splicing of the rTS gene product and its overexpression in a 5-fluorouracil-resistant cell line.
    Dolnick BJ; Black AR
    Cancer Res; 1996 Jul; 56(14):3207-10. PubMed ID: 8764108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
    Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
    Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.
    Ferguson PJ; DeMoor JM; Vincent MD; Koropatnick J
    Br J Pharmacol; 2001 Dec; 134(7):1437-46. PubMed ID: 11724749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA.
    Ju J; Kane SE; Lenz HJ; Danenberg KD; Chu E; Danenberg PV
    Clin Cancer Res; 1998 Sep; 4(9):2229-36. PubMed ID: 9748143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells.
    Ferguson PJ; Collins O; Dean NM; DeMoor J; Li CS; Vincent MD; Koropatnick J
    Br J Pharmacol; 1999 Aug; 127(8):1777-86. PubMed ID: 10482907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA.
    Dolnick BJ
    Nucleic Acids Res; 1993 Apr; 21(8):1747-52. PubMed ID: 8493092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-mRNA processing enhancer (PPE) element increases the expression of an intronless thymidylate synthase gene but does not affect intron-dependent S phase regulation.
    Lee TX; Johnson LF
    J Cell Biochem; 1998 May; 69(2):104-16. PubMed ID: 9548559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.
    Berg RW; Ferguson PJ; Vincent MD; Koropatnick DJ
    Cancer Gene Ther; 2003 Apr; 10(4):278-86. PubMed ID: 12679800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.
    Jason TL; Berg RW; Vincent MD; Koropatnick J
    Gene Expr; 2007; 13(4-5):227-39. PubMed ID: 17605297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel methionine-based signaling mechanism regulating the expression of thymidylate synthase.
    Chu E
    Cancer Biol Ther; 2003; 2(4):370-1. PubMed ID: 14508107
    [No Abstract]   [Full Text] [Related]  

  • 16. ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
    Jason TL; Figueredo R; Ferguson PJ; Vincent MD; Berg RW; Koropatnick J
    DNA Cell Biol; 2008 May; 27(5):229-40. PubMed ID: 18358073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels.
    Mandola MV; Stoehlmacher J; Zhang W; Groshen S; Yu MC; Iqbal S; Lenz HJ; Ladner RD
    Pharmacogenetics; 2004 May; 14(5):319-27. PubMed ID: 15115918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of an RNA sequence that interacts with high affinity with thymidylate synthase.
    Lin X; Mizunuma N; Chen T; Copur SM; Maley GF; Liu J; Maley F; Chu E
    Nucleic Acids Res; 2000 Nov; 28(21):4266-74. PubMed ID: 11058126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rTS gene expression is associated with altered cell sensitivity to thymidylate synthase inhibitors.
    Dolnick BJ; Black AR; Winkler PM; Schindler K; Hsueh CT
    Adv Enzyme Regul; 1996; 36():165-80. PubMed ID: 8869746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.
    Berg RW; Werner M; Ferguson PJ; Postenka C; Vincent M; Koropatnick DJ; Behrend E
    J Pharmacol Exp Ther; 2001 Aug; 298(2):477-84. PubMed ID: 11454908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.